Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Type
Search by Keyword
Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Keyword
Sort By
  • Contains 1 Component(s) Includes a Live Web Event on 05/04/2023 at 10:00 AM (EDT)

    May 4, 2023

    Overview

    Pathways to Building and Sustaining a Medical Toxicology Practice is a one-day (8-hour) virtual workshop on the variety of pathways available for establishing and maintaining a satisfying career in the field of medical toxicology.

    Led by experienced active medical toxicologists from a variety of practice settings, this workshop features panel discussions comparing the most common hospital-based, non-hospital-based, and non-clinical practice models, plus presentations on additional topics of interest, including adding addiction medicine services to a medical toxicology practice, hints and tips for contract negotiation, the basics of medical billing and coding, and the need for additional research on medical toxicology practice.

    All lectures will be recorded and made available on-demand after the live-streamed event.

    Agenda | May 4, 2023

    10:00 - 10:10 AM ET | Welcome & Opening Remarks


    Panel Presentation: Hospital-Based Medical Toxicology Practice

    10:10 - 10:25 AM ET    "Phoenix Model" Admitting Service
    10:25 - 10:40 AM ET    "Pittsburgh Model" Admitting Service
    10:40 - 10:55 AM ET    Consult Service in the University Setting
    10:55 - 11:10 AM ET    Consult Service in the Community Setting
    11:10 - 11:30 AM ET    Discussion / Q&A


    11:30 - 12:00 PM ET    Break - 30 min


    Panel Presentation: Medical Toxicology Practice in Other Clinical Settings

    12:00 - 12:15 PM ET    Virtual Consult Service
    12:15 - 12:30 PM ET    Outpatient Services
    12:30 - 12:45 PM ET    Telehealth Experience in Medical Toxicology 
    12:45 - 1:00 PM ET      Interprofessional Consults
    1:00 - 1:20 PM ET        Discussion / Q&A


    1:20 - 1:50 PM ET    Break - 30 min


    1:50 - 2:20 PM ET    Adding Addiction Medicine Service to a Medical Toxicology Practice


    Panel Presentation: Non-Clinical Practice Models

    2:20 - 2:35 PM ET    Government and Public Health
    2:35 - 2:50 PM ET    Industry
    2:50 - 3:05 PM ET    Medical-Legal Consulting / Forensics
    3:05 - 3:20 PM ET    Discussion / Q&A


    3:20 - 3:50 PM ET    Break - 30 min


    3:50 - 4:50 PM ET    Negotiating Contracts

    4:50 - 5:20 PM ET    Understanding Medical Insurers and Medical Billing & Coding 101

    5:20 - 5:50 PM ET    Practice Based Research: Can We Overcome the Challenges?

    5:50 - 6:00 PM ET    Closing Remarks / Adjourn

    • Register
      • Non-member - Tier I - $250
      • Non-member - Tier II - $250
      • Non-member - Tier III - $250
      • Non-member - Tier IV - $250
      • Member - Tier I - $200
      • Member - Tier II - $200
      • Member - Tier III - $200
      • Member - Tier IV - $200
    • More Information
  • Contains 1 Component(s) Includes a Live In-Person Event on 03/31/2023 at 8:00 AM (PDT)

    March 31 - April 2, 2023

    2023 ACMT Annual Scientific Meeting

    Early bird registration ends at midnight, Thursday, February 16th!

    March 31 - April 2, 2023
    San Diego, Marriott La Jolla, San Diego, CA

    Download Event Brochure

    The ACMT Annual Scientific Meeting (ASM) is an opportunity for specialists in the field to gather together to learn from the cutting-edge research of their peers. After a 2-year hiatus, ACMT is back for a fully in-person meeting in 2023, complete with all the networking and social opportunities that make our events so rich with engagement. The day preceding the annual meeting, ACMT will have it’s Pre-Symposium on “Self-Harm, Suicidality, and the Poisoned Patient: The Intersection of Toxicology and Mental Health” on March 30th. And the day before that, on March 29th, we are delighted to announce that our sister organization, the American Academy of Clinical Toxicology (AACT) will be joining us with their own half-day Pre-Symposium “DEI in Toxicology: What it Means for Patients and Learners.”


    Continuing Education

    This activity was planned by and for the healthcare team. Continuing Education is pending for this activity. It is expected to be approved for 14.25 Interprofessional Continuing Education (IPCE) credit for learning and change. 

    Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits will be available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person. Learners should claim only the credit commensurate with the extent of their participation in the activity. 

    Purchase CE Credits


    Questions?

    Please write to ACMT at events@acmt.net.

    Registration Rates

    Learn about Registration Rate Tiers

    image

    Early-Bird Rate*

    Early-bird rates expire at midnight on FEBRUARY 16, 2023. Fees increase to the Regular Rate after this date, no exceptions.

    Cancellation Policy

    Cancellation Policy: Cancellations received in writing on or prior to February 16, 2023 will be refunded subject to a $150 processing fee. No refunds will be given after February 16, 2023. Please send cancellation request to ACMT at events@acmt.net.

    Agenda

    This agenda is subject to change. All times listed are in local, Pacific Time Zone.


    Friday, March 31, 2023


    7:45 - 8:00 AM - Welcome & Introductions


    8:00 - 9:00 AM - Platform Session 1


    9:00 - 9:45 AM

    Donovan Lectureship: Gut-Brain Axis and Psychoneuroendocrinology: Translation to Addiction Medicine

    Lorenzo Leggio, MD, PhD, Branch Chief, NIDA and NIAAA, Acting Clinical Director and Deputy Scientific Director, NIDA, National Institutes of Health, Baltimore, MD


    9:45 - 10:30 AM

    The PFAS Epidemic: Addressing The Challenge

    Alan Woolf, MD, MPH, FAAP, FACMT, FAACT, Associate Chief Medical Education Officer, Boston Children's Hospital, Boston, MA


    10:30 - 11:30 AM - Poster Session 1
    10:40 - 11:20 AM - Moderated Poster Forum 1


    11:30 - 1:00 PM - Break / Committee Meetings


    1:00 - 2:00 PM

    X-Factor: Xylazine

    Joshua DeBord, PhD, Senior Scientist, The Center for Forensic Science Research and Education, Willow Grove, PA
    Michael Levine, MD, FACMT, Associate Professor, Director of Toxicology, Department of Emergency Medicine, University of California, Los Angeles, CA
    Matthew S. Salzman, MD, Assistant Professor of Emergency Medicine, Cooper Medical School of Rowan University, Camden, NJ


    2:00 - 3:00 PM

    Tricks of the Trade: Pain and Perioperative Management in Patients with Opioid Use Disorder

    Katherine Katzung, MD, FASAM, Chair, Emergency Department; Director, Toxicology & Addiction Medicine Program, Abbott Northwestern Hospital, Minneapolis, MN
    JoAn Laes, MD, FACMT, FASAM, Addiction Medicine Physician, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN
    Timothy Wiegand, MD, FACMT, FAACT, DFASAM, Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY


    3:00 - 3:30 PM

    Annual Review of Medical Toxicology Publications - Articles You May Have Missed from 2022-2023

    Daniel J. McCabe, MD, Director of the Division of Medical Toxicology & Associate Medical Director, University of Iowa & Iowa Poison Control Center, Iowa City, IA


    3:30 - 5:00 PM - Break / Committee Meetings


    5:00 - 6:30 PM - ACMT Annual Members Meeting and Awards Ceremony


    6:30 - 8:00 PM - 30th Anniversary - President's Reception


    Saturday, April 1, 2023


    7:45 - 8:00 AM - Morning Announcements

    Becker Medal Presentation


    8:00 - 9:00 AM - Platform Session 2


    9:00 - 9:30 AM

    MedTox and Modern Warfare: Radiation and Current Events

    Ziad Kazzi, MD, FAAEM, FACEP, FACMT, FAACT, Professor of Department of Emergency Medicine Professor, Emory University, Atlanta, GA


    9:30 - 10:15 AM

    ACMT Career Achievement Award | B is for Botulism

    B. Zane Horowitz, MD, FACMT, Associate Medical Director of Oregon-Alaska-Guam Poison Centers; Medical Director of Utah Poison Control Center; Professor of Emergency Medicine, Oregon Health and Science University, Portland, OR


    10:15 - 11:15 AM - Poster Session 2
    10:25 - 11:05 AM - Moderated Poster Forum 2


    11:15 - 12:15 PM

    AACT Panel

    Meghan Spyres, MD, FACMT, Clinical Associate Professor of Emergency Medicine, Banner – University Medical Center Phoenix, Phoenix, AZ
    Joshua D. Trebach, MD, Emergency Medical Physican and Medical Toxicologist, University of Iowa Hospitals and Clinics, Iowa City, IA


    12:15 - 2:15 PM - Break / Committee Meetings


    2:15 - 3:45 PM - MedTox Case Panel: Case-Based Conundrums


    3:45 - 5:15 PM - MedTox Shark Tank Research Forum


    5:15 - 6:45 PM - Open Mic Competition


    Sunday, April 2, 2023


    7:50 - 8:00 AM - Morning Announcements


    8:00 - 9:00 AM - Lightning Oral Session


    9:00 - 10:00 AM

    International Sessions

    APAMT: Insight to Aluminum Phosphide Poisoning and its Treatment
    Nasim Zamani, MD, Fellowship of Clinical Toxicology, Shahid Beheshti University, Aliso Viejo, CA

    EAPCCT: Tetrodotoxin Poisoning and Lessepsian Migration to The Mediterranean Sea
    Ophir Lavon, MD, Head, Clinical Pharmacology and Toxicology Unit, Carmel Medical Center, Haifa, Israel

    MENATOX: Environmental and Occupational Challenges in Lebanon with the Current Situation
    Tharwat El Zahran, MD, Assistant Professor of Emergency Medicine, Co-director of Toxicology Service, American University of Beirut Medical Center, Beirut, Lebanon


    10:00 - 11:00 AM - Poster Session 3
    10:10 - 10:50 AM - Moderated Poster Forum 3


    11:00 - 11:25 AM - (pick 1 of 2)

    Professional Development Workshops 1 & 2

    Workshop 1: A Toxicologist Loose in the Med School, Opportunities for Undergraduate Medical Education
    Brenna Michelle Farmer, MD, MBA, MS, Vice Chief of Clinical Services, Department of Emergency Medicine, NYP Brooklyn Methodist Hospital, New York City, NY
    Jeffrey Suchard, MD,Professor of Clinical Emergency Medicine; Associate Dean for Basic Science Education, University of California, Irvine, Irvine, CA
    Matthew Zuckerman, MD, Associate Professor, University of Colorado School of Medicine, Aurora, CO

    Workshop 2: The 7 Words You Can't (shouldn't) Say in Toxicology Publications
    Howard Greller, MD, FACMT, Associate Professor of Emergency Medicine, Rutgers University New Jersey Medical School, Newark, NJ
    Mark B. Mycyk, MD, FACMT, FACEP, Chair of Research, Cook County Health, Chicago, IL
    Kevin C. Osterhoudt, MD, MS, FACMT, Director, Section of Clinical Toxicology, Children’s Hospital of Philadelphia


    11:35 - 12:00 PM - (pick 1 of 2)

    Professional Development Workshops 3 & 4

    Workshop 3: Can you Escape the Toxin? Developing your own Toxicology Escape Room for Adult Leaners
    Alexis Cates, Attending Physician, Emergency Medicine and Medical Toxicology, Ochsner Medical Center, New Orleans, LA

    Workshop 4: Supplementing Toxicology Fellowship Training to Enhance the Practice of Addiction Medicine
    Leslie R. Dye, MD, FACMT, FASAM, FACCT, Clinical Professor, Emergency Medicine, Assistant Medical Director, Wright State University/Boonshoft School of Medicine, OneFifteen, Dayton, OH


    12:00 - 12:30 PM 

    A Brief History of Pharmaceutical Compounding and the Errors Associated with It

    Christopher James Watson, MD, Emergency Medicine Attending Physician, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Boston, MA
    James D. Whitledge, MD, Medical Toxicology Fellow, Boston Children's Hospital, Boston, MA


    12:30 - 1:00 PM

    Novel Treatments in the Pipeline for Envenomations

    Nicklaus Brandehoff, MD, Assistant Clinical Professor, Toxicology Associates, Aurora, CO


    1:00 - 1:30 PM

    Making Social Media Nontoxic to Toxicologists

    Joshua D. Trebach, MD, Emergency Medical Physican and Medical Toxicologist, University of Iowa Hospitals and Clinics, Iowa City, IA
    Ryan Marino, MD, Assistant Professor, University Hospitals Cleveland & Case Western Reserve University School of Medicine, Cleveland, OH


    1:30 - 2:00 PM

    What You Need to Know About MyToxCert and Recertifying in Medical Toxicology

    Robert G. Hendrickson, MD, FACMT, FACEP, FAACT, Director, Emergency Medicine Toxicology Fellowship; Associate Medical Director, Oregon Poison Center; Professor of Emergency Medicine, School of Medicine, Oregon Health & Science University, Portland, OR
    Andrew Ian Stolbach, MD, MPH, FACMT, Associate Professor of Emergency Medicine, Johns Hopkins Medicine, Baltimore, MD

    Katherine Boyle, MD

    Director of Global Patient Safety & Risk Management

    Alnylam Pharmaceuticals

    Katherine Boyle, MD is an emergency medicine physician and medical toxicologist who recently took a position at Alnylam Pharmaceuticals as Director of Global Patient Safety & Risk Management. She was previously an attending at Beth Israel Deaconess Medical Center (BIDMC) and an Assistant Professor of Emergency Medicine at Harvard Medical School. At BIDMC, she was the Director of the Division of Medical Toxicology and Associate Director of Research for the Emergency Department. In addition, she was a faculty member for the Boston Children's Hospital medical toxicology fellowship and the MA/RI Poison Control Center.  She is a graduate of the University of Massachusetts Medical School where she stayed to complete her emergency medicine residency and medical toxicology fellowship.

    Nicklaus Brandehoff, MD

    Assistant Clinical Professor

    Toxicology Associates

    Dr. Brandehoff is board certified in emergency medicine, medical toxicology, and addiction medicine with a focus on envenomation research. He has an appointment as Assistant Clinical Professor of Emergency Medicine at the University of Colorado School of Medicine and is faculty at the Rocky Mountain Poison and Drug Center. He is also the President and Medical Director for the Asclepius Snakebite Foundation, a 501(c)3 non-profit, that focuses on improving snakebite education and management in West Africa.

    Alexis Cates, DO

    Attending Physician, Emergency Medicine and Medical Toxicology

    Ochsner Medical Center

    Alexis Cates, DO trained in Emergency Medicine and Medical Toxicology at Einstein Medical Center in Philadelphia, PA.  She recently returned home to New Orleans, LA and is now working to develop a Medical Toxicology division at Ochsner Medical Center.  Professionally, she enjoys academics, perinatal toxicology, and health policy.  She is the mother of two active boys, and she and her husband enjoy road trips and adventures with the kids.

    Peter Chai, MD, MMS

    Assistant Professor

    Brigham and Women's Hospital

    Dr. Peter R Chai is an assistant professor of emergency medicine and medical toxicology at Brigham and Women’s Hospital/Harvard Medical School, and affiliate research scholar at the Koch Institute for Integrated Cancer Research at the Massachusetts Institute of Technology, and The Fenway Institute. He is also research faculty at the Dana Farber Cancer Institute. Dr. Chai’s research primarily involves the development and implementation of technological solutions that detect and respond to changes in disease. These translational projects ranges from design of novel robotic and sensor systems in animal models to human clinical trials to test the implementation of injectable and ingestible sensor systems and overlying behavioral science architecture to respond to disease states.  Specifically, Dr. Chai is interested in applying ingestible electronic sensor systems to understand medication adherence in the context of substance use and HIV treatment/prevention. His work in developing ingestible sensors and their overlying behavioral interventions as closed loop systems to measure, reinforce and provide tools for PrEP and ART adherence has been funded by the National Institutes of Health and industry partners.

    Joshua DeBord, PhD

    Senior Scientist

    The Center for Forensic Science Research and Education

    Dr. Joshua (Josh) DeBord is a Senior Scientist at the CFSRE working in the areas of forensic toxicology and forensic chemistry. Dr. DeBord joined the CFSRE in early 2022 and performs R&D on challenging toxicological casework and profiles physical drug evidence on projects related to the CFSRE’s drug characterization initiatives, including CFSRE’s NPS Discovery program.

    Dr. DeBord graduated with a B.S., M.S., and Ph.D., each in Chemistry, from Florida International University (FIU) in Miami, FL. Dr. DeBord’s doctoral research was conducted under the mentorship of Professor José Almirall on profiling and geographic provenance determination of heroin. Before joining CFSRE, Dr. DeBord was employed at the North Louisiana Crime Lab in Shreveport, LA, as a forensic chemist and toxicologist. Beginning there in 2018, Dr. DeBord and two colleagues started the toxicology section from only blood ethanol analysis to ISO/IEC 17025:2017 accreditation for qualitative determination and quantitative measurement of most drugs by March 2020. He also assisted with the development and implementation of the North Louisiana Crime Lab’s statistical sampling procedure to reduce backlog in the large-seizure drug casework. He continued to perform casework analysis and expert testimony before joining CFSRE in 2022.

    Dr. DeBord is passionate about teaching, research, and mentorship. His research interests focus on applied research for increasing the capabilities of publicly funded forensic labs and improving the work experience for forensic professionals.

    Leslie R. Dye, MD, FACMT, FASAM, FACCT

    Clinical Professor, Emergency Medicine, Assistant Medical Director

    Wright State University/Boonshoft School of Medicine, OneFifteen

    Leslie R. Dye, MD is triple board certified in emergency medicine, medical toxicology, and addiction medicine. She has worked in the fields of medical toxicology and addiction medicine for 30 years. In addition to her clinical expertise, she has academic and business content expertise from experiences as an editor-in-chief (EIC) of a peer-reviewed medical journal (Journal of Medical Toxicology) and EIC of physician and pharmacist content production for a leading international medical digital content provider. Her deep subject matter expertise is demonstrated in her role as senior editor of the textbook, Case Studies in Medical Toxicology, author of 18 peer reviewed publications and 16 textbook chapters, 66 national and 11 international presentations, 10 various commentaries, interviews, and podcasts. Her leadership skills have been proven in both corporate and academic environments, as professor at a medical school, long-term board member and past president of the American College of Medical Toxicology, Chair of the Addiction Medicine Committee, former co-chair, and co-moderator of the AACT Acute and Intensive Care Symposium, and as the manager of as many as 30 team members at an international corporation. She received a funded grant that enabled her to start the first poison control center in mainland China and trained 6 Chinese physicians in the field of medical toxicology over 3 years in the US. Dr. Dye is experienced in and continues to provide medical care in remote polar regions with no access to advanced medical facilities.

    Tharwat El Zahran, MD

    Medical Director, Assistant Professor of Emergency Medicine

    American University of Beirut Medical Center

    Dr. Tharwat El Zahran is an Assistant Professor of Emergency Medicine and the Medical director for the emergency department at the American University of Beirut Medical Center (AUBMC)

    She completed a fellowship training in medical toxicology at Emory University and CDC, and currently co-directs the medical toxicology service at AUBMC.

    Brenna Farmer, MD, MBA, MS

    Vice Chair & Chief of Emergency Medicine

    NYP Brooklyn Methodist Hospital & Weill Cornell Medicine Department of Emergency Medicine

    Dr. Brenna Farmer is Chief of Emergency Medicine at NY Presbyterian Brooklyn Methodist Hospital and Vice Chair in the Department of Emergency Medicine at Weill Cornell Medicine's Department of Emergency Medicine. She trained in Emergency Medicine at Vanderbilt University Medical Center and in toxicology at NYU/Bellevue and the New York City Poison Control Center. She earned her medical degree from East Carolina University's Brody School of Medicine and her executive MBA from Cornell and MS in Healthcare Leadership from Cornell's Weill Cornell Graduate School of Medical Sciences. Her major academic interests are medication safety, patient safety, and acute bedside care of the toxicologic patient.

    Howard Greller, MD, FACMT

    Associate Professor of Emergency Medicine

    Rutgers University New Jersey Medical School

    Rob Hendrickson, MD

    Professor of Emergency Medicine, Medical Director, Program Director

    Oregon Health and Science University, Oregon Poison Center, OHSU Fellowship in Medical Toxicology

    Dr. Hendrickson is a Professor of Emergency Medicine and Medical Toxicologist at the Oregon Health and Science University (OHSU) in Portland, Oregon. He is the Program Director of the Fellowship in Medical Toxicology at OHSU and the Medical Director of the Oregon Poison Center, serving Oregon, Alaska, and Guam.

    B. Zane Horowitz, MD, FACMT

    Associate Medical Director

    Oregon-Alaska-Guam Poison Centers

    Dr. B. Zane Horowitz served as the medical director of the Oregon-Alaska-Guam Poison Center for 22 years. He also served as the medical director for the Utah Poison Control Center for 7 of those years. He currently continues to teach at Oregon Health and Science University in medical toxicology, and has authored over 90 publications.

    Katherine Katzung, MD, FACEP, FASAM

    Director of Addiction & Toxicology Program & Emergency Care Physician

    Abbott Northwestern Hospital & Emergency Care Consultants

    Katherine Katzung, MD is an attending physician in the emergency department at Abbott Northwestern, where she serves as chair of the department.  Additionally, she is the medical director of the hospital’s addiction medicine and toxicology program, which began in 2020 after she received grant funding to initiate a hospital-based toxicology/addiction medicine consult service as well as an  emergency department-based addiction medicine "bridge" clinic to provide continuity of care for patients initiated on Suboxone.  This innovative program allows patients evaluated at Abbott Northwestern in the emergency department or inpatient units continuity of care, while focusing on harm-reduction strategies, until they can be given a warm hand-off to community providers.

    A graduate of the University of Minnesota School of Medicine, she completed emergency medicine training at Regions Hospital in St. Paul and additional fellowship training in medical toxicology.  She is board certified in emergency medicine, medical toxicology, and addiction medicine.  Her clinical interests surround the intersection of these 3 specialties, with special focus on early ED & hospital-based interventions to evaluate and treat substance use disorder, including initiation of medication assisted therapies.

    She volunteers as a consultant for the Minnesota Poison Control System in addition to serving on the board of the Steve Rummler HOPE Network and acts as medical director of its overdose prevention program.

    Ziad Kazzi, MD, FAAEM, FACEP, FACMT, FAACT

    Professor, Department of Emergency Medicine

    Emory University School of Medicine

    Born in 1975 and raised in Beirut, Lebanon, Dr. Kazzi trained in Emergency Medicine at Emory University in Atlanta (2000-03) where he served as a chief resident before completing a subspecialty fellowship in Medical Toxicology at Emory University, Georgia Poison Center and the Centers for Disease Control and Prevention (CDC) in Atlanta. He is board certified in both Emergency Medicine and Medical Toxicology. Dr. Kazzi joined the Department of Emergency Medicine at the University of Alabama at Birmingham (UAB) between 2005 and 2008 where he served as a Medical Toxicologist for the Regional Poison Control Center in Birmingham and the Alabama Poison Center. Currently, he is an associate professor at the department of Emergency Medicine at Emory University in Atlanta, Georgia as well as the director of the International Toxicology Postdoctoral Fellowship Program at Emory University (http://www.em.emory.edu/services/toxicology/international_postdoc_training.html).

    He is also the assistant medical director of the Georgia Poison Center (www.georgiapoisoncenter.org) and a medical toxicologist at the Radiation Studies Branch of the National Center for Environmental Health at the CDC (https://www.cdc.gov/nceh/radiation/) where he participates in emergency preparedness and response activities in radiation.

    As an emergency physician and toxicologist, Dr. Kazzi specializes in the recognition, triage, and management of poisonings and holds a deep interest in the areas of Radiation and International Toxicology. Over the past decade, he developed strong ties to India in the areas of medical toxicology, mass gathering medical preparedness, radiation emergency medicine, blast injuries and hazmat. Through his collaboration with the CDC, AIIMS, and PGIMER Chandigarh, he has delivered and co-directed the first Advanced Hazmat Life Support trainings in Ahmedabad and Delhi. He organized a number of training conferences in Nashik, Pune, Ujjain and Delhi and has been an invited speaker at the annual INDUS EM world congress. He is an active and founding board member of the Middle East North Africa Toxicology Association (www.menatox.org) and currently serves as its President. He is also a board member and chairs the International Committee of the American College of Medical Toxicology (www.acmt.net).

    JoAn Laes, MD, DFASAM, FACMT

    Addiction Staff Physician

    Abbott Northwestern Hospital, Allina Health

    JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

    Lorenzo Leggio, MD, PhD

    Branch Chief & Acting Clinical Director

    NIDA & NIAAA

    Dr. Lorenzo Leggio is a Senior Investigator in the NIH Intramural Research Program (IRP) with faculty appointments both at NIDA and NIAAA. He serves as Chief of the Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, a joint NIDA and NIAAA laboratory. He also serves as the NIDA Deputy Scientific Director, NIDA Acting Clinical Director, and Chief of the NIDA IRP Translational Addiction Medicine Branch. He also serves as a NIH Senior Attending Medical Staff and as senior medical advisor to the NIAAA Director. Dr. Leggio received his M.D. and Ph.D. from the Catholic University of Rome and ‘Agostino Gemelli’ hospital, where he also completed residency and received Board Certification in Internal Medicine. He was a visiting research associate, then postdoctoral research associate in Psychiatry and Human Behavior at Brown University, Providence, RI. In 2010, he joined the faculty of the Brown University Medical School as Assistant Professor at the Brown University Center for Alcohol and Addiction Studies, where he still holds an adjunct appointment as Professor in Behavioral and Social Sciences. He is also an Adjunct Professor of Addiction Medicine at Johns Hopkins University and Adjunct Professor of Neuroscience at Georgetown University. 

    Dr. Leggio’s clinical research has been primarily focused on the treatment of alcohol and substance use disorders, with a special emphasis on the role of microbiome-gut-liver-brain and neuroendocrine pathways as well as GABAergic pathways; and on the medical consequences of alcohol use disorder, focusing on alcohol-associated liver disease. As a Principal Investigator at Brown University, Dr. Leggio received extramural research funding from NIAAA and NIDA, as well as from Brown University, the European Foundation for Alcohol Research, ABMRF/The Foundation for Alcohol Research, and the Brain and Behavior Research Foundation (NARSAD Young Investigator Award). At Brown University first, and at the NIH since 2012, Dr. Leggio, together with his team, colleagues and collaborators have pioneered and conducted work on medication development, on the role of the microbiome-gut-liver-brain axis and on the role of neuroendocrine pathways in addictive behaviors via human laboratory studies and clinical trials as well as via translational and reverse translational experimental medicine approaches. 

    In 2022, Dr. Leggio was elected Fellow of the American College on Neuropsychopharmacology. Among other awards, Dr. Leggio received the 2008 Nordmann Award from the European Society for Biomedical Research on Alcoholism, the 2016 Early Career Investigator Award from the Research Society on Alcoholism, the 2018 Eva King Killam Award from the American College on Neuropsychopharmacology and the 2020 Jacob P. Waletzky Award from the Society for Neuroscience.

    Michael Levine, MD, FACMT

    Associate Professor of Emergency Medicine

    University of California, Los Angeles

    Michael Levine is a Los Angeles native, who completed his emergency medicine residency at the Harvard Affiliated Emergency Medicine program, based out of Brigham and Women’s Hospital and Massachusetts General Hospital. After residency, he completed his medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ. After staying as faculty for a year in Phoenix, he moved back to Los Angeles, where he joined the faculty at USC. He is currently the division chief of medical toxicology. He is actively involved in patient care, research, and serves on numerous hospital and university committees. He is an active member of American College of Emergency Physicians, the American College of Medical Toxicology, and is a member of the Toxicology Investigator's Consortium.

    Dan McCabe, MD

    Director of the Division of Medical Toxicology & Associate Medical Director

    University of Iowa & Iowa Poison Control Center

    Dr. Dan McCabe is a medical toxicologist and emergency medicine physician at the University of Iowa Hospitals & Clinics, as well as a Clinical Assistant Professor of Emergency Medicine at the University of Iowa, the Director of the Division of Medical Toxicology at the University of Iowa, and the Associate Medical Director for the Iowa Poison Control Center. Dr. McCabe received his medical degree from the University of Iowa. He completed a residency in emergency medicine at Cook County Hospital and a fellowship in medical toxicology at the Regions Hospital/Minnesota Poison Control System. Dr. McCabe has a broad range of interests including improvement of care for the poisoned patient, toxicology, addiction medicine, resource utilization, and public health.

    Elizabeth Moore, DO

    Assistant Professor of Clinical Emergency Medicine

    Weill Cornell Medicine

    Dr. Moore is currently an Assistant Professor of Clinical Emergency Medicine and Medical Toxicology at Weill Cornell Medicine in New York City.  She completed her Emergency Medicine Residency training at Lehigh Valley Health Network in and her Fellowship in Medical Toxicology at Banner-University Medical Center in Phoenix. She is actively involved in Women in Toxicology (WiT), and helps to produce the  “Tox in Ten” and “ ACMT Highlights” Podcast.

    Mark Mycyk, MD

    Chair of Research

    Cook County Health

    Mark Mycyk currently serves as Editor-in-Chief of Journal of Medical Toxicology and Chair of Research in the Department of Emergency Medicine at Cook County Health in Chicago.

    Todd Phillips, MD

    Director of Toxicology

    Integrative Emergency Services

    Dr. Phillips is a graduate of Texas A&M University, Class of 2007, with a Bachelor’s in Biomedical Science.  He completed medical school at Texas Tech University School of Medicine in 2011 and attended the University of Pittsburgh for both residency in Emergency Medicine and fellowship in Medical Toxicology from 2011 – 2016.  Following graduation, he accepted a position at John Peter Smith in Fort Worth, Texas where he served as their Assistant Program Director for the Emergency Medicine residency program and founded the inaugural Division of Medical Toxicology.  Dr. Phillips then transitioned to University of Texas Southwestern in Dallas, Texas where he served as the Program Director of the Medical Toxicology Fellowship. Dr. Phillips is looking forward to his upcoming transition to Director of Toxicology for Integrative Emergency Services in Dallas/Fort Worth. His professional interests include medical education, medical toxicology advocacy, and alcohol withdrawal. 

    Matthew Salzman, MD

    Assistant Professor

    Cooper Medical School of Rowan University

    Matthew Salzman received his Bachelor of Arts in Music from the University of Rochester and his Medical Degree from the Sidney Kimmel Medical College at Thomas Jefferson University.  He trained in Emergency Medicine and Medical Toxicology at Drexel University College of Medicine.  Currently, he is an Assistant Professor of Emergency Medicine in the Division of Medical Toxicology and Addiction Medicine at Cooper Medical School of Rowan University.  He is the Medical Director for the In-patient Addiction Medicine Consult service as well as Medical Director for Research for Addiction Medicine at Cooper.  He is also a volunteer consultant in toxicology for the Children's Hospital of Philadelphia and the Philadelphia Poison Control Center.

    Jeffrey Suchard, MD

    Professor of Clinical Emergency Medicine & Associate Dean for Basic Science Education

    University of California, Irvine

    Jeffrey Suchard is an Emergency Physician and Medical Toxicologist at the University of California, Irvine.  After undergraduate studies in Biochemistry at UC Berkeley, he attended medical school at UCLA, EM residency at UConn, then completed medical toxicology fellowship in Phoenix, AZ.  Dr. Suchard has worked clinically at UC Irvine since 1999 and began his current involvement in medical student education in 2010.  He teaches Epidemiology & Biostatistics to the MS1 class (since 2010), is the course director for MS2 Medical Pharmacology (since 2011), and serves as Associate Dean for Basic Science Education (since 2014).

    Trevonne Thompson, MD

    Professor of Emergency Medicine & Medical Toxicology

    University of Illinois College of Medicine/Toxikon Consortium

    Dr. Trevonne M. Thompson is an attending emergency physician and medical toxicologist at UI Health and a tenured professor of Emergency Medicine and Medical Toxicology at the University of Illinois College of Medicine (UICOM). He obtained his undergraduate degree from Xavier University of Louisiana in New Orleans. After graduating with a degree in Biology and minors in Chemistry and Spanish, he attended medical school at the Feinberg School of Medicine at Northwestern University in Chicago. He served his emergency medicine residency at Cook County Hospital (now Stroger Hospital of Cook County). After serving as Chief Resident in Emergency Medicine, he completed a Medical Toxicology fellowship at the Toxikon Consortium in Chicago. Dr. Thompson is the head of the Division of Medical Toxicology within the Department of Emergency Medicine at UICOM. He leads the medical toxicology consultation service and clinic at UI Health. He is a consultant to the Illinois Poison Center and is an associate program director for the Toxikon Consortium Medical Toxicology Fellowship.

    Dr. Thompson is the Associate Dean for Admissions for the University of Illinois College of Medicine. He is a past chair of the Emergency Medicine Section of the National Medical Association.

    Michael Toce, MD, MS

    Instructor of Pediatrics

    Boston Children's Hospital/Harvard Medical School

    Dr. Michael Toce completed his undergraduate studies at Carleton College where he received a B.A. in biology and biochemistry. He received a M.S. in bacteriology from the University of Wisconsin-Madison, and his M.D. from the Medical College of Wisconsin. He completed his pediatrics residency at the Boston Combined Residency Program before completing a Medical Toxicology Fellowship and Pediatric Emergency Medicine Fellowship at Boston Children's Hospital. He is currently an attending in the Boston Children's Hospital Emergency Department and works as a Medical Toxicologist at the MA/RI Poison Control Center.

    Joshua Trebach, MD

    Emergency Medicine Physician & Medical Toxicologist

    University of Iowa Hospitals and Clinics

    Josh Trebach is an emergency medicine physician and medical toxicologist at the University of Iowa Hospital and Clinics. He completed his undergraduate training at Virginia Tech, medical school training and residency at Johns Hopkins, and toxicology fellowship at New York University/New York City Poison Control Center. Josh is currently the Director of Resident Medical Toxicology Education at the University of Iowa and is passionate about all things toxicology, medical education, social media, LGBTQ health, and animal rescue.

    James Whitledge, MD

    Medical Toxicology Fellow

    Boston Children's Hospital

    James Whitledge, MD is a Medical Toxicology Fellow at Boston Children's Hospital in Boston, MA. He is also an Emergency Physician at Beth Israel Deaconess Medical Center Boston, MA. In his free time he also is the current Co-Chair of the AACT Herbs & Dietary Supplements Section.

    Alan D. Woolf, MD, MPH, FACMT, FAAP, FACCT

    Associate Chief Medical Education Officer

    Boston Children's Hospital

    Dr. Alan D. Woolf is a pediatrician and medical toxicologist. He is the Associate Chief Medical Education Officer at Boston Children’s Hospital and a Professor of Pediatrics at Harvard Medical School. He is Medical Director of the Pediatric Environmental Health Center at Boston Children’s Hospital, Director of the Pediatric Environmental Health Fellowship Training Program, and Principal Investigator of the Region 1 New England Pediatric Environmental Health Specialty Unit. He is currently a member of the Executive Committee of the American Academy of Pediatrics’ Council on Environmental Health & Climate Change and a member of the PFAS Subcommittee of the National PEHSU Program. Dr. Woolf has served as a consultant regarding PFAS water contamination to both the New Hampshire and Massachusetts Departments of Public Health since 2014. He co-authored one of the first papers to describe the PFAS water contamination event in Portsmouth NH and was a ‘Community Liaison’ giving input to the NASEM Report on PFAS published in 2022. He is currently a member of the New Hampshire State Advisory Committee on PFAS and cancer. 

    Dr. Woolf is a past-president of both the American Academy of Clinical Toxicology and the American Association of Poison Control Centers. In 2018, Dr. Woolf received the Career Achievement Award from the AACT and, in 2019, he was named the Louis Roche Lecturer by the European Association of Poisons Centers and Clinical Toxicologists. He is the Editor of the recent book The History of Modern Clinical Toxicology published by Elsevier Publishers in 2021.

    Nasim Zamani, MD

    Fellowship of Clinical Toxicology

    Shahid Beheshti University

    Nasim Zamani graduated from Azad University of Medical Sciences in Tehran, Iran in 2004. She started residency in Forensic Medicine and Clinical Toxicology in 2008 and finished the course with the first rank of the national board followed by fellowship program in clinical toxicology in Loghman Hakim Hospital- one of the largest in-patient clinical toxicology centers in the world- in affiliation with Shahid Beheshti University of Medical Sciences. After graduation, She started to work in the same setting as attending physician in 2014 where she was responsible for patient treatment, teaching, and research in the field. She has won three international grants in the field of clinical toxicology and is currently a board member of APAMT and a member of EAPCCT.

    Matthew Zuckerman, MD

    Associate Professor

    University of Colorado School of Medicine

    Dr. Matt Zuckerman is an medical toxicologist at the University of Colorado Anschutz Medical Campus and Rocky Mountain Poison & Drug Safety. He is the pharmacology content director for the CU School of Medicine curriculum.

    Continuing Education

    This activity was planned by and for the healthcare team. Continuing Education is pending for this activity. It is expected to be approved for 14.25 Interprofessional Continuing Education (IPCE) credit for learning and change. 

    Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits will be available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person. Learners should claim only the credit commensurate with the extent of their participation in the activity. 

    Purchase CE Credits

    • Register
      • Early bird pricing available!
      • Non-member - Tier I - $795
      • Non-member - Tier II - $500
      • Non-member - Tier III - $400
      • Non-member - Tier IV - $350
      • Member - Tier I - $650
      • Member - Tier II - $425
      • Member - Tier III - $350
      • Member - Tier IV - $300
      • Regular Price after 02/17/2023 12:59 AM
      • Non-member - Tier I - $995
      • Non-member - Tier II - $600
      • Non-member - Tier III - $500
      • Non-member - Tier IV - $450
      • Member - Tier I - $750
      • Member - Tier II - $525
      • Member - Tier III - $450
      • Member - Tier IV - $400
    • More Information
  • Contains 1 Component(s) Includes a Live In-Person Event on 03/30/2023 at 8:00 AM (PDT)

    March 30, 2023

    Download Event Brochure

    2023 ACMT Symposium | Self-Harm, Suicidality, and the Poisoned Patient: The Intersection of Toxicology and Mental Health
    Thursday, March 30, 2023
    San Diego, Marriott La Jolla, San Diego, CA

    Suicide is a major public health problem and leading cause of preventable death. The practice of medical toxicology often involves caring for patients who injure themselves (or attempt injury) by poisoning. Toxic exposures may affect the central nervous system, cause neuropsychiatric symptoms, and increase the likelihood of future suicidal behavior. 

    "Toxicologists interact on a daily basis with patients who have myriad mental health problems, and in many cases those sufferings increase the risk of suicide,” says symposium organizer Mark Su, MD, MPH, FACMT. “As providers for patients with intentional xenobiotic exposures and suicide attempts, the toxicology community must be cognizant of these complex issues and understand substantive ways to address them in real time." 

    This symposium will discuss the ethics, psychology, management, and global epidemiology of the suicidal patient through the toxicology lens. Clinicians will also learn about lethal means restriction, care of the “frequent attempter,” and strategies to prevent death by suicide. Ultimately, the course will hopefully help us better understand the suicidal toxicology patient and improve their care. 

    This program brings together distinguished experts in Medical Toxicology, Psychiatry, Emergency Medicine, Medical Ethics, Military Medicine, Addiction Medicine, Public Health and related fields. 

    Topics include: 

    Ethical Issues in Treatment and Research 
    Ethical Allocation of Resources: Transplant and the Suicidal Patient 
    Psychology of Suicidal Behavior and Access to Means 
    The Role of Medical Toxicology in Prevention of Suicidality 
    The High Utilizer and Recurrent Suicidality 
    Special Populations: Neuropsychiatric Consequences of Military and Occupational Exposures
    The Intersection of Forensic Toxicology & Suicide: How To Determine Death by Suicidal Intent 
    The event will conclude with “A Global Perspective on Suicide by Self-Poisoning” panel featuring international medical and public health experts representing the U.S., Scotland, Lebanon, Australia, and France. 


    Continuing Education

    This activity was planned by and for the healthcare team. Continuing Education is pending for this activity. It is expected to be approved for 6.25 Interprofessional Continuing Education (IPCE) credit for learning and change. 

    Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits will be available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person. Learners should claim only the credit commensurate with the extent of their participation in the activity. 

    Purchase CE Credits

    Agenda

    All times listed in local, Pacific Time Zone.


    7:45 - 8:00 AM - Opening Remarks


    8:00 - 8:45 AM

    Caring for the Suicidal Patient: Ethical Issues in Treatment and Research

    Dominic Sisti, PhD, Associate Professor, Department of Medical Ethics & Health Policy, University of Pennsylvania, Pennsylvania, PA


    8:45 - 9:15 AM

    Ethical Allocation of Resources: Transplant and the Suicidal Patient

    Filza Hussain, MD Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry, Stanford University, Stanford, CA


    9:15 - 9:45 AM

    Psychology of Suicidal Behavior

    Elizabeth Ballard, PhD, Associate Scientist, NIMH, Silver Spring, MD


    9:45 - 10:15 AM

    Access to Means

    J.J. Rasimas, MD, FAACT, FACLP, FACMT., FACPsych, Professor of Psychiatry and Emergency Medicine, University of Minnesota, Penn State College of Medicine, Health PEI, Charlottetown, PE  Canada


    10:15 - 10:30 AM - Morning Break


    10:30 - 11:00 AM

    The Role of Med Tox in Prevention of Suicidality

    Larissa K. Laskowski, DO, Assistant Professor, NYU Grossman School of Medicine, NYU Langone Health, Health + Hospitals Bellevue, New York, NY


    11:00 - 11:30 AM

    Recurrent Suicidality

    Yaron Finkelstein, MD, FACMT, Professor of Pediatrics, Pharmacology and Toxicology at the University of Toronto, Clinician-Investigator faculty at The Hospital for Sick Children, Toronto, Ontario, Canada


    11:30 - 12:00 PM

    The High Utilizer Through the Lens of Suicidality

    Gregory Carter, M.B.B.S. FRANZCP, PhD, Conjoint Professor in Psychiatry,School of Medicine and Public Health at the University of Newcastle, Waratah, NSW, AUS


    12:00 - 1:30 PM - Lunch Break


    1:30 - 2:00 PM

    Neuropsychiatric Consequences of Occupational and Environmental Exposures

    Mike Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP, Director of Occupational Medicine, Saratoga Hospital, Saratoga Springs, NY


    2:00 - 2:30 PM

    Neuropsychiatric Consequences of Military Exposures

    CAPT (Dr.) Paul Sargent, 21st Century Sailor Office (OPNAV N17), U.S. Navy


    2:30 - 3:00 PM

    The Intersection of Forensic Toxicology & Suicide: How To Determine Death by Suicidal Intent

    Steven Campman, MD, Chief Medical Examiner, San Diego County, San Diego, CA


    3:00 - 4:00 PM

    Panel | Global Perspective on Suicide by Self-Poisoning

    Michael Eddleston, MD, Professor of Clinical Toxicology, University of Edinburgh, Edinburgh, Scotland, United Kingdom
    Tharwat El Zahran, MD, Assistant Professor of Emergency Medicine and Medical Toxicology, Co-director, Toxicology Services, American University of Beirut, Beirut, Lebanon
    Andrew Dawson, MD, Clinical Professor of Clinical Pharmacology and Toxicology & Central Clinical School, University of Sydney, Australia
    Bruno Mégarbane, MD, Head of the Department of Medical and Toxicological Critical Care, Paris Cité University Lariboisière Hospital, Paris, France
    CAPT (Dr.) Josh Schier, MD, MPH, USPHS, Chief Medical Officer, United States Public Health Service (USPHS) Commissioned Corps, Senior Medical Officer and Medical Toxicologist, Assistant Professor, Dept of Emergency Medicine, Section of Toxicology, CDC, Emory University of Medicine, Atlanta, GA

    Elizabeth Ballard, PhD

    Director of Psychology and Behavior Research, Predoctoral Training

    Experimental Therapeutics and Pathophysiology Branch

    Dr. Elizabeth Ballard is the Director of Psychology and Behavior Research and the Director of Predoctoral Training at the Experimental Therapeutics and Pathophysiology Branch in the National Institute of Mental Health.  She is trained as a clinical psychologist from the Catholic University of America and has extensive clinical experience working with suicidal patients.  She completed her predoctoral internship at the Department of Veterans Affairs Eastern Colorado Health Care System and a postdoctoral fellowship at Johns Hopkins School of Medicine. As an associate scientist, she is the Lead Associate Investigator on the Neurobiology of Suicide Protocol in the Intramural Program of the NIMH.  She has published over 95 articles and her research interests include short term risk factors for suicide and rapid acting treatments for suicidal thoughts.

    Steven Campman, MD

    Chief Medical Examiner

    San Diego County

    Dr. Campman is San Diego County’s Chief Medical Examiner.  He earned his B.S. in Biology from Loyola Marymount University in 1987; graduated from Creighton University School of Medicine in Omaha, in 1992, and then completed residency in Anatomic and Clinical Pathology at the University of California, Davis Medical Center, in 1997.  Following fellowship training in Forensic Pathology with the Northern California Forensic Pathology Group at the Sacramento County Coroner’s Office in 1998, he went to work for the US Air Force and was stationed at the Office of the Armed Forces Medical Examiner, the Armed Forces Institute of Pathology, in Washington DC, as Associate, then Deputy and Chief Deputy Medical Examiner for Medicolegal Operations and Investigations, until he went to work for the County in 2001 (later continuing to serve in the Air Force Reserve as a Regional Medical Examiner until he retired).  He is Board Certified in Anatomical/Clinical, and Forensic Pathology, and leads the Medical Examiner’s Department while continuing to regularly perform autopsies, and testify in CA Superior Court.

    Gregory Carter, M.B.B.S. FRANZCP, PhD

    Acting Director of Dept. Consultation Liaison Psychiatry & Conjoint Professor in Psychiatry

    University of Newcastle School of Medicine and Public Health

    Professor Carter is currently the Senior Staff Specialist and Acting Director of Dept. Consultation Liaison Psychiatry, Calvary Mater Newcastle Hospital, Waratah; and Conjoint Professor in Psychiatry in the College of Health, Medicine and Wellbeing, School of Medicine and Public Health, University of Newcastle. He is a Chief Investigator for the NHMRC Centre of Research Excellence in Suicide Prevention (CRESP 2.0). He is the Chair for the RANZCP for the Clinical Practice Guidelines for Deliberate Self-Harm, a member of the Presidents Suicide Advisory Committee and the RANZCP representative to the Prime Minister’s Suicide Advisory Group.

    Current areas of clinical and research interest include; deliberate self-poisoning, suicide prevention, epidemiology of suicidal behaviours, delirium, screening for depression, somatisation, organ donation and psycho-oncology.

    Andrew Dawson, FRCP, FRACP, FCCP, FAMCT, FEAPCCT

    Director National Poisons Register & Clinical Toxicology

    Royal Prince Alfred Hospital

    Andrew Dawson is an Australian Clinical Pharmacologist and Toxicologist whose major interest is in translational clinical toxicology research to produce changes in policy and clinical practice.

    He established the Australian Hunter Area Toxicology Service in Newcastle in 1987, research included interventions for deliberate self-harm, relative toxicity of drugs in overdose and prediction of toxicity.

    In 2004 he moved to Sri Lanka to establish the South Asian Clinical Toxicology Research Collaboration. This group built sustainable research capacity addressing deliberate self-harm with pesticides and improved clinical practice in resource poor settings. This research contributed to policy that reduced Sri Lankan national suicide deaths by 50%

    In 2010 he returned to Australia and became the Director of Clinical Toxicology Royal Prince Alfred Hospital, and the Director of the New South Wales Poison Information Centre (to 2021) at the Childrens Hospital Westmead. He is Clinical Professor Medicine, University of Sydney and Adjunct Professor School of Medicine University of NSW. Current interests include management of institutional responses to patients with challenging self-harm behaviours, substance use disorder and self-harm, evaluating the effects of regulatory changes on incidence of deliberate self-harm.

    Michael Eddleston, ScD, FRCP(Edin), FBPhS, FEAPCCT, FRSE, RCPE, Cullen Gold Medalist

    Professor of Clinical Toxicology

    The University of Edinburgh

    My work’s major aim is to reduce deaths from pesticide and plant self-poisoning in rural Asia, a cause of over 200,000 premature deaths each year and a key global means of suicide. To do this, I perform clinical trials in South Asian district hospitals to better understand the pharmacology and effectiveness of antidotes and community-based controlled trials to identify effective public health interventions. This work is complemented by translational studies of antidotes in minipig models of poisoning in a large animal critical care laboratory that I established in Edinburgh, work with sociologists and anthropologists to better under-stand the meaning of self-harm, and work with the WHO and FAO to aid implementation. I work with pesticide regulators through the Centre for Pesticide Suicide Prevention. I also perform clinical and animal research in Edinburgh to improve treatment of other forms of poisoning (such as from cyanide, alcohol, and contrast media) by developing and/or testing novel antidotes.

    Tharwat El Zahran, MD

    Medical Director, Assistant Professor of Emergency Medicine

    American University of Beirut Medical Center

    Dr. Tharwat El Zahran is an Assistant Professor of Emergency Medicine and the Medical director for the emergency department at the American University of Beirut Medical Center (AUBMC)

    She completed a fellowship training in medical toxicology at Emory University and CDC, and currently co-directs the medical toxicology service at AUBMC.

    Michael Holland, MD, FACMT, FEAPCCT, FAACT, FACOEM, FACEP

    Director of Occupational Medicine

    Saratoga Hospital

    Michael Holland is the  Director of Occupational Medicine for the Saratoga Hospital Medical Group, Saratoga Hospital Employee Health Medical Director,  Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY,  Consulting Medical Toxicologist at the Upstate New York Poison Center and at the Onondaga County Medical Examiner’s Office-both in Syracuse, NY, and Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.  Dr. Holland has ABMS Board Certifications in Occupational Medicine, Medical Toxicology, Emergency Medicine, and Addiction Medicine.

    Filza Hussain, MD

    Clinical Associate Professor

    Stanford University

    Filza Hussain, MD, is a Clinical Associate Professor of Psychiatry at Stanford University School of Medicine. She attended medical school in Pakistan and completed her residency training at the Mayo Clinic, Minnesota and a Consultation Liaison Psychiatry fellowship at Columbia University in New York. Her clinical focus is transplant psychiatry and she serves as the liaison to the Liver and Kidney transplant programs at Stanford. Other areas of clinical/research interests include Personality disorders, Suicidology, Cultural Psychiatry, and medical pedagogy.

    Larissa Laskowski, DO

    Assistant Professor

    NYU Grossman School of Medicine, NYU Langone Health, Health + Hospitals Bellevue

    Larissa Laskowski is a clinical assistant professor and medical toxicologist at NYU Grossman School of Medicine, and serves as a consultant for the New York City Poison Control Center. She is also cofounder and director of The Prevention Education Partnership (PEP), an initiative dedicated to decreasing the incidence of preventable illness and injury commonly seen in the emergency department. Through PEP Talks, a harm-reduction drug education curriculum, she deploys doctors into local schools to educate middle and high school students, teachers, and parents, in an effort to keep NYC youth safe, healthy, and out of the ER. Due to the rapidly evolving threat of teen fentanyl overdose, she is currently laser-focused on ensuring that every student, teacher, and parent knows how to recognize an opioid overdose and save a life by administering naloxone. 

    She currently resides in Manhattan with her husband Mike and two small children Frida and Miles.

    Bruno Megarbane, MD, PhD

    Head of the Department of Medical and Toxicological Critical Care

    Paris Cité University Lariboisière Hospital

    Bruno Mégarbane is Professor of critical care medicine at Paris University and directs a research team at INSERM UMRS-1144. He is the Head of the Department of Medical and Toxicological Critical Care at Lariboisière Hospital, Paris, France. He conducted several clinical and experimental studies in clinical toxicology.

    J.J. Rasimas, MD, PhD, FAACT, FACLP, FACMT, FACPsych

    Professor of Psychiatry & Emergency Medicine

    University of Minnesota & Penn State College of Medicine

    Dr. Rasimas attended the University of Scranton and graduated summa cum laude with degrees in biochemistry, mathematics, and philosophy. He completed the Medical Scientist Training Program at Penn State University, earning a Ph.D. in chemical biology (2002) and M.D. (2003). Upon graduation from the Penn State College of Medicine, Dr. Rasimas matriculated to psychiatry residency training at the Mayo Clinic in Rochester, Minnesota. He was a clinical fellow at the NIMH, training in consultation-liaison psychiatry, bioethics, and clinical research. Dr. Rasimas has studied psychoanalytic psychotherapy at the Minnesota Psychoanalytic Society and Institute and the Washington School of Psychiatry. He served as a C-L psychiatrist for Milton S. Hershey Medical Center and remains an Associate Professor of Psychiatry and Emergency Medicine for the Penn State College of Medicine, there. He completed the critical care based medical toxicology fellowship at Penn State, obtained board certification in addiction medicine, and then returned to NIMH to join the Undiagnosed Diseases Program and the Intramural Research Program to oversee clinical trials in mood and anxiety disorders. He is also a Fellow of the Academy of Psychosomatic Medicine and a Laughlin Fellow with membership in the American College of Psychiatrists. Dr. Rasimas is a Professor at the University of Minnesota, pursuing an academic medical career at the interface of psychosomatic medicine, medical toxicology, and psychodynamic psychotherapy with a primary clinical interest in the phenomenology of suicide. His current clinical position is the director of Consultation-Liaison Psychiatry services for the Queen Elizabeth Hospital in Charlottetown, Prince Edward Island.

    Joshua Schier, MD, MPH

    Chief Medical Officer

    USPHS Commissioned Corps, CDC

    CAPT Joshua G Schier, MD MPH was appointed the 9th Chief Professional Officer of the Medical Category of the Commissioned Corps of the U.S. Public Health Service (Corps) in November 2021. As the Chief Medical Officer, CAPT Schier provides leadership and direction for Corps medical officers and advises the Office of the Surgeon General and the Department of Health and Human Services (HHS) on recruitment, assignment, deployment, retention, and career development of Corps physicians. CAPT Schier is currently assigned to the CDC's National Center for Injury Prevention and Control (NCIPC), Division of Overdose Prevention (DOP) as a Senior Medical Officer. At CDC, he serves as a Strategy Lead for CDC’s Overdose Data to Action Program overseeing activities related to linking overdose patients to care and supporting providers and health systems across 66 states, counties, and metropolitan areas. He is the CDC/ATSDR Site Director for the joint Emory/CDC Medical Toxicology Fellowship and serves as a subject matter expert for CDC in Medical Toxicology for informing various activities related to stimulants and other drugs of abuse. CAPT Schier spent 15 years at CDC’s National Center for Environmental Health, where he oversaw national real-time surveillance activities for poisoning events via PCC data, radiation disaster preparedness activities, and provided expert clinical consultation for suspected and known domestic and international mass poisoning incidents. He served two terms on ABEM’s Medical Toxicology Sub-Board and has published more than 75 articles in peer-reviewed journals and CDC’s Morbidity and Mortality Weekly Report.

    Dominic Sisti, PhD

    Associate Professor, Department of Medical Ethics & Health Policy

    University of Pennsylvania

    Dominic Sisti, PhD, is an associate professor in the Department of Medical Ethics & Health Policy at the University of Pennsylvania. He directs the Scattergood Program for the Applied Ethics of Behavioral Health Care and holds secondary appointments in the Department of Psychiatry, where he directs the ethics curriculum in the residency program, and the Department of Philosophy. Dr. Sisti examines ethical and policy challenges in mental health care, including long-term psychiatric care for individuals with serious mental illness and clinical ethics issues in correctional settings. Sisti's research also explores ethical issues in psychedelic research and clinical application.

    Registration Rates

    Click here to learn more about ACMT registration tiers.

    image

    Early-Bird Rate*

    Early-bird rates expire at midnight on FEBRUARY 16, 2023. Fees increase to the Regular Rate after this date, no exceptions.

    Cancellation Policy

    Cancellation Policy: Cancellations received in writing on or prior to February 16, 2023 will be refunded subject to a $150 processing fee. No refunds will be given after February 16, 2023. Please send cancellation request to ACMT at events@acmt.net.

    Continuing Education

    This activity was planned by and for the healthcare team. Continuing Education is pending for this activity. It is expected to be approved for 6.25 Interprofessional Continuing Education (IPCE) credit for learning and change. 

    Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits will be available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person. Learners should claim only the credit commensurate with the extent of their participation in the activity. 

    Purchase CE Credits

    • Register
      • Early bird pricing available!
      • Non-member - Tier I - $350
      • Non-member - Tier II - $250
      • Non-member - Tier III - $175
      • Non-member - Tier IV - $150
      • Member - Tier I - $250
      • Member - Tier II - $200
      • Member - Tier III - $125
      • Member - Tier IV - $100
      • Regular Price after 02/17/2023 12:59 AM
      • Non-member - Tier I - $400
      • Non-member - Tier II - $300
      • Non-member - Tier III - $225
      • Non-member - Tier IV - $200
      • Member - Tier I - $300
      • Member - Tier II - $250
      • Member - Tier III - $175
      • Member - Tier IV - $150
    • More Information
  • Contains 1 Component(s) Includes a Live In-Person Event on 03/29/2023 at 12:45 PM (PDT)

    March 29, 2023

    Download Event Brochure

    ACMT is delighted to host the American Academy of Clinical Toxicology (AACT), for a half-day symposium at our Spring Meeting! 

    2023 AACT Symposium | DEI in Toxicology: What it Means for Patients and Learners
    Wednesday, March 29, 2023
    San Diego, Marriott La Jolla, San Diego, CA

    Supporting and increasing the diversity, equity and inclusion of members of the toxicology community is paramount. However, so is increasing our knowledge of the diverse patient populations so that we are providing equitable and inclusive care. The first half of the symposium will cover content related to the disabled patient, alternative medicine use, toxicological skin manifestations on darker skin, and hormone toxicities in transgender patients. The second half will focus on diversity, equity and inclusion, in the Medical Toxicology specialty. Join the American Academy of Clinical Toxicology (AACT) as we explore this crucial topic together. See agenda for more info!


    Continuing Education

    This activity was planned by and for the healthcare team. Continuing Education is pending for this activity. It is expected to be approved for 4.0 Interprofessional Continuing Education (IPCE) credit for learning and change. 

    Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits will be available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person. Learners should claim only the credit commensurate with the extent of their participation in the activity. 

    Purchase CE credit

    Registration Rates

    Click here to learn more about ACMT registration tiers.

    image

    AACT Member Discount

    If you are an AACT Member, you are eligible for a registration discount! Enter AACT at checkout to receive a $50 registration discount. Does not apply to ACMT Members.

    Early-Bird Rate*

    Early-bird rates expire at midnight on FEBRUARY 16, 2023. Fees increase to the Regular Rate after this date, no exceptions.

    Cancellation Policy

    Cancellation Policy: Cancellations received in writing on or prior to February 16, 2023 will be refunded subject to a $150 processing fee. No refunds will be given after February 16, 2023. Please send cancellation request to ACMT at events@acmt.net.

    Agenda

    Talk times and topics are subject to change. All times listed in local, Pacific Time Zone.


    12:45 - 1:00 PM - Opening Remarks


    1:00 - 1:30 PM

    Toxicology in the Disabled Patient: Baclofen Pumps & Muscle Relaxers

    Justin Seltzer, MD, Medical Toxicology Fellow, UC San Diego Division of Medical Toxicology, San Diego, CA


    1:30 - 2:00 PM

    The Culturally Competent Tox History: Assessing for Potential Exposures Associated with Herbal Folk Remedies, Cosmetics, and Ethnic Foods

    Michael Yeh, MD, MS, Medical Officer, National Center for Environmental Health, Atlanta, GA


    2:00 - 2:30 PM

    Toxicology of Herbal Remedies - Continued

    Kevin J. Mercer, PharmD, MPH, Clinical Pharmacist, HCA Houston Healthcare, Houston, TX


    2:30 - 3:00 PM

    Gender Affirming Care: Hormone Toxicities in the Transgender Patient

    Haylee Veazey, MD, Faculty Physician, Emergency and Internal Medicine, Hennepin County Medical Center, Minneapolis, MN


    3:00 - 3:15 PM - Break


    3:15 - 3:45 PM

    Toxicology of Medical Abortifacients

    Garry Winkler, Assistant Professor of Emergency Medicine and Medical Toxicology, University of Texas Health Science Center Houston, Houston, TX


    3:45 - 4:15 PM

    Microaggressions: How to be an Ally

    Adam Overberg, PharmD, BCPS, DABAT, Managing Director, Indiana Poison Center, Indianapolis, IN


    4:15 - 4:45 PM

    How to Implement Holistic Review in a Toxicology Fellowship Program

    Jeff Druck, MD, FACEP, Vice Chair of Faculty Advancement, DEI, and Wellbeing for Emergency Medicine, University of Utah, Salt Lake City, UT


    4:45 - 5:15 PM

    Turning Talk Into Action - Future Directions for Tox

    Peter Akpunonu, MD, FAAEM, FFSEM, FACEP Associate Professor, Emergency Medicine & Medical Toxicology, Director, Medical Toxicology, Director, Undersea & Hyperbaric Medicine, Director, Radiation Injury Treatment Network, University of Kentucky Hospital, Medical Director, Kentucky Poison Control Center, Louisville KY

    Jeffrey Druck, MD, FACEP

    Vice Chair of Faculty Advancement, DEI, and Wellbeing for Emergency Medicine

    University of Utah

    Dr. Druck went to medical school at Baylor College of Medicine, followed by residency at Denver Health.  He currently serves as the Vice Chair of Faculty Advancement, DEI, and Wellbeing for the Department of Emergency Medicine at the University of Utah, as well as serving on the board of SAEM. His interests include mentorship, wellbeing, diversity, equity and inclusion (DEI), medical education, and the intersection of education and clinical care. He has been involved in medical education at the undergraduate level, graduate level, and CME level.  From a DEI perspective, he has been involved in DEI efforts on an undergraduate, graduate, and national level.

    Research interests: mentoring, medical education, wellbeing, DEI

    Justin Seltzer, MD

    Medical Toxicology Fellow

    UC San Diego

    Dr. Justin Seltzer was born and raised in San Diego, CA. He did both his undergraduate studies and medical school at the University of Southern California in Los Angeles, CA. He completed residency training in emergency medicine at Northwestern University in Chicago, IL. Within toxicology, his interests include pharmaceutical drug toxicity, antidote development and drug repurposing, and hazardous materials such as chemical warfare agents, pesticides, industrial chemicals, and radiation exposure.

    Continuing Education

    This activity was planned by and for the healthcare team. Continuing Education is pending for this activity. It is expected to be approved for 4.0 Interprofessional Continuing Education (IPCE) credit for learning and change. 

    Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits will be available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person. Learners should claim only the credit commensurate with the extent of their participation in the activity. 

    Purchase CE credit

    • Register
      • Early bird pricing available!
      • Non-member - Tier I - $175
      • Non-member - Tier II - $150
      • Non-member - Tier III - $125
      • Non-member - Tier IV - $100
      • Member - Tier I - $125
      • Member - Tier II - $100
      • Member - Tier III - $75
      • Member - Tier IV - $50
      • Regular Price after 02/17/2023 12:59 AM
      • Non-member - Tier I - $200
      • Non-member - Tier II - $175
      • Non-member - Tier III - $150
      • Non-member - Tier IV - $125
      • Member - Tier I - $150
      • Member - Tier II - $125
      • Member - Tier III - $100
      • Member - Tier IV - $75
    • More Information
  • Contains 4 Component(s) Includes a Live Web Event on 02/16/2023 at 1:00 PM (EST)

    Cases to be announced

    Cases:

    • To be announced.

    Series Moderator: Lewis Nelson, MD, FACMT, Rutgers New Jersey Medical School, Newark, NJ

    About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. NCC is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

    This webinar is for ACMT members only.

  • Contains 4 Component(s) Includes a Live Web Event on 02/07/2023 at 12:00 PM (EST)

    Methylene Chloride

    Methylene Chloride

    Presenter: Dr. Richard Harrison


    Series Moderator: Nicholas E. Nacca, MD, Assistant Professor of Emergency Medicine, University of Rochester Medical Center, Rochester, NY

    About The Series: ACMT's Grand Rounds offer an in-depth and interactive platform for learning and discussion about issues that impact the research and practice of medical toxicology. Experts from within and outside medical toxicology will share their knowledge and experience and highlight areas for collaboration and mutual understanding.

    This webinar is for ACMT members only.

  • Contains 4 Component(s) Includes a Live Web Event on 02/03/2023 at 1:00 PM (EST)

    Topic to be announced.

    Case information coming soon!


    Series Moderators

    • Timothy J. Wiegand, MD, FACMT, DFASAM (ACMT/ASAM Expert), Director of Toxicology and of the Toxicology Consult Service, University of Rochester Medical Center, Rochester, NY  
    • Gloria J. Baciewicz, MD (ASAM Expert), Addiction Psycharcist, Strong Recovery; Professor of Clinical Psychiatry, Department of Psychiatry, University of Rochester Medical Center, Rochester, NY

    Panelists

    • To be announced.

      About The Series: The ACMT/ASAM Addiction Toxicology Case Conference webinar series discusses Addiction/Toxicology cases in an interactive fashion featuring experts from Addiction Medicine, Addiction Psychiatry, and Medical Toxicology.

      This webinar is open to the public.

      • Register
        • Non-member - Tier I - Free!
        • Non-member - Tier II - Free!
        • Non-member - Tier III - Free!
        • Non-member - Tier IV - Free!
        • Member - Tier I - Free!
        • Member - Tier II - Free!
        • Member - Tier III - Free!
        • Member - Tier IV - Free!
      • More Information
    • Contains 3 Component(s) Includes a Live Web Event on 01/31/2023 at 12:00 PM (EST)

      Dr. Sarah Eliza Dunn will discuss the history of how superstition was eventually dispelled by science which led to unprecedented advances in public health.

      In 1900 the average life-expectancy in the US was 45 & 45% of the population farmed. By 2000, 2% of the population farmed and life expectancy had increased by 35 years. This webinar covers the history of how superstition was eventually dispelled by science which led to unprecedented advances in public health. Unfortunately, the current pandemic gave rise to doubt about the scientific method, and superstitious beliefs have re-emerged, threatening the very advances that brought us health, comfort, and prosperity.

      There will be an opportunity for Q&A engagement with the speaker.

      About the Series
      This webinar series is sponsored by the Medical Toxicology Foundation (MTF) and Bayer. The focus of this series is to highlight opportunities, particularly for fellows-in-training beyond the academic track, and introduce them to the possibility of a career in industry. This series will be of particular interest to fellows-in-training and junior faculty, but registration is open to all.

      Sarah Eliza Dunn (Halcomb), MD, FACMT

      Medical Affairs Lead, Senior Science Fellow

      Bayer U.S. Crop Science

      Eliza Halcomb is the Medical Sciences and Outreach Lead for Bayer. She is an Emergency Medicine physician and Medical Toxicologist with a long-standing interest in Global Health. After completing her Toxicology Fellowship at NYU in 2006, Dr. Dunn returned to Washington University in St. Louis and started an ACGME accredited fellowship in Medical Toxicology. She organized a relief mission to Haiti after the 2010 earthquake, started the scholar track in Global Health for the Washington University Division of Emergency Medicine, and is one of the Global Health Scholars for the Department of Internal Medicine. She remains on the faculty of Washington University and is still an active member of the Toxicology team.

      • Register
        • Non-member - Tier I - Free!
        • Non-member - Tier II - Free!
        • Non-member - Tier III - Free!
        • Non-member - Tier IV - Free!
        • Member - Tier I - Free!
        • Member - Tier II - Free!
        • Member - Tier III - Free!
        • Member - Tier IV - Free!
      • More Information
    • Contains 2 Component(s)

      1. A 56-year-old man with a history of diabetes, hypertension, severe restrictive lung disease secondary to covid pneumonia presents with one day of fatigue, dyspnea on exertion, dry cough, and hypoxia (79% at home pulse oximetry). Patient states the symptoms began acutely, two hours after getting home from work the day prior. He reports that a few other co-workers have similar symptoms as him or they have nausea, abdominal pain, vomiting. He thinks a virus is going around his workplace. 2. A 51-year-old man presents with a diffuse rash over the past 6 days that developed after he ingested a product for sexual stimulation called “royal honey” that he obtained at a local shop. His VS are normal and he is in no distress. 3. A 2-year-old girl is extracted from underneath debris from a structural fire; she was found covered in soot and is pulseless. CPR is initiated and ROSCis achieved within minutes. She arrives to the ED with the following vital signs: BP, 95/58; HR, 130; RR, 28; SaO2, 100% on NRB; T, 98.6F. She is only responsive to pain and is promptly intubated.

      Cases:

      • A 56-year-old man with a history of diabetes, hypertension, severe restrictive lung disease secondary to covid pneumonia presents with one day of fatigue, dyspnea on exertion, dry cough, and hypoxia (79% at home pulse oximetry). Patient states the symptoms began acutely, two hours after getting home from work the day prior. He reports that a few other co-workers have similar symptoms as him or they have nausea, abdominal pain, vomiting. He thinks a virus is going around his workplace. 
      • A 51-year-old man presents with a diffuse rash over the past 6 days that developed after he ingested a product for sexual stimulation called “royal honey” that he obtained at a local shop. His VS are normal and he is in no distress.
      • A 2-year-old girl is extracted from underneath debris from a structural fire; she was found covered in soot and is pulseless. CPR is initiated and ROSCis achieved within minutes. She arrives to the ED with the following vital signs: BP, 95/58; HR, 130; RR, 28; SaO2, 100% on NRB; T, 98.6F. She is only responsive to pain and is promptly intubated. 

        Series Moderator: Lewis Nelson, MD, FACMT, Rutgers New Jersey Medical School, Newark, NJ

        About The Series: ACMT's National Case Conference (NCC) is a monthly webinar for ACMT members that features interesting cases seen by medical toxicologists nationwide. NCC is an educational endeavor and a quality improvement effort intended to improve patient care. It is not intended to define standard of care. Attempts have been made to ensure HIPAA compliance. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

        This webinar is for ACMT members only.

      1. Contains 2 Component(s)

        This month's topic is "Treatment of Cyclopeptide Mushroom Poisoning". The articles will be reviewed by the VCU Program in Medical Toxicology and led by Dr. Brandon Wills.

        Topic: Treatment of Cyclopeptide Mushroom Poisoning
        Presented By: VCU Program in Medical Toxicology, led by Dr. Brandon Wills.

        Articles

        • Mackenzie CA, et al: Cyclosporine as a novel treatment for amatoxin-containing mushroom poisoning: a case series. Toxicol Commun 2022;6:23-27.
        • Tan JL, et al: Amanitin intoxication: effects of therapies on clinical outcomes – a review of 40 years of reported cases. Clin Toxicol 2022;DOI 10.1080/15563650.2022.2098139
        • Mengs U, Pohl R-T, Mitchell T, Legalon SIL: The antidote of choice in patients with acute toxicity from amatoxin poisoning. Curr Pharmaceut Biotech 2012;13:1964-1970.
        • Tong TC: Comparative treatment of alpha-Amanitin poisoning with N-acetylcysteine, benzylpenicillin, cimetidine, thioctic acid and silybinin in a murine model. Ann Emerg Med 2007;50:282-288.

        Series Moderator: Steven E. Aks, DO, FACEP, FACMT, Toxikon Consortium

        About The Series: ACMT's National Journal Club (NJC) is a bimonthly member webinar hosted by a different fellowship program each session. All data and information provided in this activity is for informational purposes only. ACMT makes no representations as to accuracy, completeness, currentness, suitability, or validity of the content and will not be liable for any errors or omissions in this information or any losses, injuries, or damages arising from its display or use.

        This webinar is for ACMT members only.